Pfizer said Thursday that it is back in the race to get an effective weight-loss pill to market. The company’s announcement, ...

Pfizer is moving forward with a weight-loss pill as the drug maker seeks to crack the multibillion-dollar market for obesity medications and mount a comeback from its post-pandemic malaise.

Keep an eye on these stocks as the weight loss drug market stabilizes and Uncle Sam steps into the pricing picture.

Pfizer doesn't currently produce any anti ... it won't have a first-to-market advantage in pill-based weight loss drugs. Nor will it have an efficacy advantage, barring an unexpectedly favorable ...

It also has an underrated opportunity in the promising weight loss market as it works on developing a daily pill to help ...

Pfizer pins hopes on daily pill to crack market for weight-loss drugs on facebook (opens in a new window) Pfizer pins hopes on daily pill to crack market for weight-loss drugs on linkedin (opens ...

Pfizer said earlier this month that it’s moving forward with a weight-loss pill that would rival injectable medicines like Novo Nordisk A/S’s Wegovy. Pfizer’s pill is slated to enter mid ...

PFIZER ADVANCES ONCE-DAILY WEIGHT-LOSS PILL IN ONGOING STUDY CEO Thomas Schinecker told the Financial Times in an interview published Monday that the company's first drug could be available ...

Pfizer’s weight loss pill portfolio is being expanded in the competitive GLP-1 market by studying two other pills along with danuglipron. Over time, the launch of these therapies may have an ...

Pfizer's weight loss pill portfolio is being expanded in the competitive GLP-1 market by studying two other pills along with danuglipron. Over time, the launch of these therapies may have an effect on ...